Correlations between eNOS polymorphisms and decreased NO bioavailability or endothelial dysfunction have also been reported [13, 18, 19], and reduced eNOS expression has been recently found in AD brain [20]. The gene discussed is NOS3; the disease is Alzheimer disease.